Financing ·
Organogenesis Holdings Inc. entered into an At-the-Market Sales Agreement with BTIG, LLC and Citizens JMP Securities…
ORGOOrganogenesis Holdings Inc.
Organogenesis Holdings Inc. entered into an At-the-Market Sales Agreement with BTIG, LLC and Citizens JMP Securities, LLC on August 6, 2026, authorizing the sale of up to $75,000,000 in Class A common stock from time to time. The company will pay agents a commission of up to 3.0% of gross sales price. This offering is conducted under an effective shelf registration statement filed on August 8, 2024. Organogenesis Holdings Inc. operates in the medical device industry, specializing in regenerative medicine and wound care solutions.